Core B: Clinical

$1,043,991U19FY2016AGNIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications, trials & patents

Paper 39574713 Paper 39528671 Paper 39484387 Paper 39310214 Paper 39220624 Paper 39147830 Paper 39129354 Paper 39118132 Paper 39102080 Paper 38977137 Paper 38823249 Paper 38664422 Paper 38496536 Paper 38344221 Paper 38327094 Paper 38264712 Paper 38204173 Paper 38191573 Paper 38109776 Paper 38089920 Paper 38036915 Paper 38014176 Paper 37986731 Paper 37849657 Paper 37745408 Paper 37742656 Paper 37653343 Paper 37595576 Paper 37546928 Paper 37522277 Paper 37509130 Paper 37398476 Paper 37345460 Paper 37293032 Paper 37214955 Paper 37035880 Paper 37034653 Paper 36994162 Paper 36978190 Paper 36934675 Paper 36909631 Paper 36865237 Paper 36752121 Paper 36744337 Paper 36700738 Paper 36415591 Paper 36216518 Paper 36017766 Paper 35925685 Paper 35903538 Paper 35791732 Paper 35756247 Paper 35611306 Paper 35551019 Paper 35468989 Paper 35425899 Paper 35398188 Paper 35218111 Paper 35213370 Paper 34862382 Paper 34686968 Paper 34564904 Paper 34184058 Paper 34125126 Paper 34095836 Paper 33249440 Paper 33231528 Paper 33169416 Paper 32989109 Paper 32973425 Paper 32920988 Paper 32873693 Paper 32729964 Paper 32614981 Paper 32568366 Paper 32424284 Paper 32222300 Paper 32211504 Paper 32182160 Paper 32116503 Paper 31994170 Paper 31935468 Paper 31932050 Paper 31888969 Paper 31880315 Paper 31874745 Paper 31755958 Paper 31555121 Paper 31506247 Paper 31372540 Paper 31319126 Paper 31231205 Paper 31012816 Paper 31001108 Paper 30927606 Paper 30842300 Paper 30627880 Paper 30586384 Paper 30578620 Paper 30528841

Abstract

CLINICAL CORE - CORE B: ABSTRACT The Clinical Core (Core B) plays a pivotal role in the BIOCARD Study. The Clinical Core is responsible for: (1) the re-enrollment of BIOCARD subjects, (2) scheduling subjects for all visits and all study procedures (including clinical/cognitive assessments, lumbar punctures for collection of cerebrospinal fluid, magnetic resonance imaging (MRI) scans, and positron emission tomography scans using Pittsburgh compound B (PiB/PET scans), (3) completion of annual clinical and cognitive assessments, (4) acquisition of ante-mortem autopsy approval, (5) implementation of subject retention activities, (6) analyses of clinical and cognitive data concerning the study participants, (7) working collaboratively with the other Cores to examine combinations of biomarkers that are predictive of progression and to examine the order and pattern of biomarker change during preclinical AD, and (8) sharing of clinical and cognitive data with investigators in the field via the BIOCARD website, using the approved BIOCARD Study data sharing procedures.

View original record on NIH RePORTER →